Your gut bacteria may already be making an NAD+ precursor that works through a different pathway than NMN or NR. A new Science Advances study reports that this molecule, N-MNA, is produced by certain commensal and probiotic bacteria, taken up by fly, mouse and human cells, and converted to NAD+ via the Preiss-Handler pathway. People with gut dysbiosis and inflammation had less of it in stool, and supplementing it boosted intestinal stem cell regeneration and epithelial repair in flies and mice. The catch is that this is animal and lab work only, with no human trial and no product you can buy. Here is what it shows, and what it doesn't.
This page is available in